Authors: Mohamed Shouman1, Serap Tari2, Friederike Mumm3, Morten Hoyer4, Jesper Grau Eriksen5, Cecile Le Péchoux6, Anne Laprie7, David Krug8, Umberto Ricardi9, Vincenzo Valentini10, Barbara Alicja Jereczek-Fossa11,12, Icro Meattini13, Mirjam Mast14, Ben Slotman15, Bradley R Pieters15, Laura Motisi16, Agata Rembielak17, Anna M Kirby18, Carsten Nieder19, Carl Salembier20, Sławomir Blamek21, Pedro C Lara22, Felipe Couñago23, Yolande Lievens24, Piet Ost25, Renée Bultijnck26, Katja Kuehlmeyer27, Fiona McDonald28, Pierre Blanchard29, Matthias Guckenberger16, Claus Belka1
1University Hospital, LMU München, Department of Radiation Oncology, Munich, Germany; 2Comprehensive Cancer Center Munich (CCC Munich LMU), Lebensmut e.V., Munich, Germany; 3University Hospital, LMU Munich, Department of Internal Medicine III, Munich, Germany; 4Aarhus University, Danish Center for Particle Therapy, Aarhus, Denmark; 5Aarhus University Hospital, Aarhus, Department of Experimental Clinical Oncology, Aarhus, Denmark; 6Gustave Roussy Cancer Campus, Department of Radiation Oncology, Villejuif, France; 7Claudius Regaud Institute, Toulouse University Cancer Institute-Oncopole, Radiation Oncology Department,, Toulouse, France; 8University Hospital Schleswig-Holstein, Department of Radiation Oncology, Kiel, Germany; 9University of Turin, Department of Oncology-Radiation Oncology, Turin, Italy; 10Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Radiation Oncology and Hematology Department, Roma, Italy; 11University of Milan, Department of Oncology and Hemato-Oncology, Milan, Italy; 12IEO European Institute of Oncology IRCCS, Division of Radiation Oncology, Milan, Italy; 13Azienda Ospedaliero Universitaria Careggi, Radiation Oncology Unit, Oncology Department, Florence, Italy; 14Haaglanden Medical Center, Research&Development, Leidschendam, The Netherlands; 15Amsterdam University Medical Center, Department of Radiation Oncology, Amsterdam, The Netherlands; 16University Hospital Zurich, University of Zurich, Department of Radiation Oncology, Zurich, Switzerland; 17The Christie NHS Foundation Trust, Department of Clinical Oncology, Manchester, United Kingdom; 18Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Department of Radiotherapy, Sutton, United Kingdom; 19Nordland Hospital, Department of Oncology and Palliative Medicine, Bodø, Norway; 20Europe Hospitals, Department of Radiotherapy, Brussels, Belgium; 21Maria Skłodowska-Curie National Research Institute of Oncology, Department of Radiotherapy, , Gliwice, Poland; 22San Roque University Hospital, Fernando Pessoa Canarias University, Canarian Comprehensive Cancer Center, Las Palmas, Spain; 23San Francisco de Asís and La Milagrosa Hospitals, Department of Radiation Oncology, Madrid, Spain; 24Ghent University Hospital and Ghent University, Department of Radiation Oncology, Ghent, Belgium; 25Ghent University Hospital, Department of Radiation Oncology and Experimental Cancer Research, Ghent, Belgium; 26Ghent University, Department of Human Structure and Repair, Ghent, Belgium; 27LMU Munich, Institute of Ethics, History and Theory of Medicine, Munich, Germany; 28Royal Marsden NHS Foundation Trust, Department of Radiotherapy, London, United Kingdom; 29Gustave Roussy, Université Paris Saclay, Department of Radiation Oncology, Villejuif, France